Target type: molecularfunction
Binding to a nucleoside, a compound consisting of a purine or pyrimidine nitrogenous base linked either to ribose or deoxyribose. [GOC:hjd]
Nucleoside binding is a molecular function that describes the interaction of a protein or other molecule with a nucleoside. Nucleosides are composed of a nitrogenous base (adenine, guanine, cytosine, thymine, or uracil) linked to a pentose sugar (ribose or deoxyribose). This interaction is essential for a wide variety of biological processes, including DNA replication and repair, RNA transcription and translation, and signal transduction. The binding of nucleosides to proteins can be highly specific, with individual proteins recognizing and binding only certain nucleosides or nucleoside analogs. The binding interaction is typically mediated by non-covalent forces, such as hydrogen bonding, van der Waals interactions, and hydrophobic interactions. The specific amino acids involved in nucleoside binding can vary depending on the protein and the nucleoside. However, common binding motifs include the purine-binding motif (PBM), the ribose-binding motif (RBM), and the deoxyribose-binding motif (DBM). These motifs often contain conserved amino acid residues that form hydrogen bonds with the sugar and base moieties of the nucleoside. The binding of nucleosides to proteins can have a number of biological effects. For example, the binding of ATP to enzymes can activate or inhibit their catalytic activity. The binding of nucleotides to DNA polymerase can promote DNA replication. And the binding of guanine nucleotides to G-protein coupled receptors can trigger signal transduction pathways. In summary, nucleoside binding is a fundamental molecular function that is essential for a wide range of biological processes. The interaction of proteins with nucleosides is highly specific and is mediated by non-covalent forces. The binding of nucleosides to proteins can have a variety of biological effects, including activation or inhibition of enzyme activity, promotion of DNA replication, and triggering of signal transduction pathways.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytidine deaminase | A cytidine deaminase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P32320] | Homo sapiens (human) |
Purine nucleoside phosphorylase | A purine nucleoside phosphorylase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P00491] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
uridine | uridines | drug metabolite; fundamental metabolite; human metabolite | |
cytidine | cytidines | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
cytarabine | beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside | antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent | |
deoxycytidine | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
3-deazaguanine | 3-deazaguanine: structure | ||
gemcitabine | gemcitabine : A 2'-deoxycytidine having geminal fluoro substituents in the 2'-position. An inhibitor of ribonucleotide reductase, gemcitabine is used in the treatment of various carcinomas, particularly non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. | organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic |
adenosine | quinquefolan B: isolated from roots of Panax quinquefolium L.; RN not in Chemline 10/87; RN from Toxlit | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
5,6-dihydrouridine | dihydrouridine : The uridine derivative obtained by formal hydrogenation of the endocyclic double bond in the uracil ring. | uridines | biomarker |
pyrimidin-2-one beta-ribofuranoside | pyrimidin-2-one beta-ribofuranoside: RN given refers to (D)-isomer; structure | pyrimidine ribonucleosides | |
2'-fluoro-2'-deoxycytidine | |||
3-deazaguanosine | 3-deazaguanosine: structure | ||
2'-c-methylcytidine | 2'-C-methylcytidine: structure in first source | ||
ag 99 | tyrphostin A46: epidermal growth factor-urogastrone receptor antagonist | ||
psi 6130 | 2'-deoxy-2'-fluoro-2'-C-methylcytidine: PSI-6130 is the (beta-D)-isomer; has antiviral activity against hepatitis C virus; structure in first source | ||
galidesivir | |||
acyclovir | acyclovir : An oxopurine that is guanine substituted by a (2-hydroxyethoxy)methyl substituent at position 9. Used in the treatment of viral infections. Acyclovir: A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. | 2-aminopurines; oxopurine | antimetabolite; antiviral drug |
guanosine monophosphate | guanosine 5'-monophosphate : A purine ribonucleoside 5'-monophosphate having guanine as the nucleobase. Guanosine Monophosphate: A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. | guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate | biomarker; Escherichia coli metabolite; metabolite; mouse metabolite |
guanine | 2-aminopurines; oxopurine; purine nucleobase | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
guanosine | ribonucleoside : Any nucleoside where the sugar component is D-ribose. | guanosines; purines D-ribonucleoside | fundamental metabolite |
inosine | inosines; purines D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | |
8-amino-9-(2-thienylmethyl)guanine | |||
allopurinol riboside | allopurinol riboside : A nucleoside analogue that is allopurinol with a beta-D-ribofuranosyl moiety at the 1-position. | nucleoside analogue | metabolite |
8-amino-9-benzylguanine | 8-amino-9-benzylguanine: structure given in first source | ||
forodesine | forodesine: structure in first source | dihydroxypyrrolidine; pyrrolopyrimidine | |
peldesine | peldesine: potent inhibitor of human CCRF-CEM T-cell proliferation; structure given in first source | ||
ci 972 | CI 972: structure given in first source | ||
8-aminoguanine | |||
acyclovir monophosphate | |||
immucillin g | immucillin G: structure in first source | dihydroxypyrrolidine; pyrrolopyrimidine | |
ulodesine | ulodesine: a purine nucleoside phosphorylase inhibitor | ||
8-bromoguanosine | purine nucleoside | ||
9-deaza-9-(3-thienylmethyl)guanine | |||
8-aminoguanosine |